Midlands Strengths

The UK’s heartbeat for cutting-edge Medicine, Life Sciences and MedTech

For further information on the Midlands incredible COVID-19 response

MI Health brings together the country’s best health research expertise with the NHS and industry. Building on legacy strengths in Manufacturing and Engineering together with internationally recognised research excellence, the Midlands is world-leading in five strength areas:

  1. Medical Technologies – The home of MedTech innovation, manufacturing and pioneering technologies in partnership with industry: 

    - With more MedTech companies than any other region in the UK, contributing £1.6bn to the UK economy, we aim to support the delivery of the 2.4% uplift in national R&D spend through our long-term plan for regional growth through the development of the Medical Technologies Innovation Accelerator (MTIA).

    - The Midlands is an internationally recognised cluster of expertise in High Field MRI and imaging techniques. We aim to become the home of Ultra High Field imaging both for clinical and research use and to have the UK’s first 11.7T MRI facility. Higher magnetic fields ultimately enable greater detail for diagnostics.

    -Linking to the nationally-recognised Centre for Regulatory Science and Innovation in Birmingham, the Midlands aims to cement the region as the leading UK region for Regulatory Science, supporting innovative businesses and accelerating patient benefit.

    - We are the UK’s manufacturing heartland. Utilising our world-leading facilities and Life Science expertise, the Midlands is the ideal home for the UK’s Life Sciences Manufacturing Hub. This initiative supports the Government’s levelling up agenda, domestic supply chain resilience, creating new jobs and supporting the region’s post-pandemic economic recovery.

    6024 UoN MTIA Logo Colour crop2
  2. Health Diversity – Leading the understanding of health inequality and delivery of inclusive research:

    The Midlands has an international reputation for inclusive clinical research excellence and world-leading academic ethnic and mental health expertise. Beacons of this include the Centre for Black Minority Health, the Keele Impact Accelerator Unit, the 3 NIHR Midlands Biomedical Research Centres, 2 NIHR Applied Research Collaborations and the Midlands Engine Mental Health and Productivity Pilot. Key disease themes include diabetes, cardiovascular, inflammation, liver, respiratory, BME health and mental health. Our strength has and continues to drive inclusive investigation into healthcare issues, showcased by the response to COVID-19; including partners in the Midlands being the first to highlight the relationship between ethnicity and COVID-19 clinical outcomes. This strength is particularly important in supporting the Government’s levelling-up agenda and post COVID-19 economic recovery plans.
      Health Diversity COVID19 report COVID19 brochure  
  3. Rehabilitation and Ageing – Driving the UK forwards:

    Home to internationally renowned academic specialism (such as those within the National Centre for Sport and Exercise Medicine) and NHS engagement facilitators (e.g. NIHR Trauma Management MedTech Co-operative), the region is the ideal environment, infrastructure and expertise for the development and production of defence- and rehabilitation-focused innovations.

    The region hosts the UK’s centre of excellence for Rehabilitation and Defence Medicine, the new £300M Defence Medical Rehabilitation Centre and will soon house the UK’s £70M National Rehabilitation Centre for civilian care, making the Midlands the place to be for the development and production of defence- and rehabilitation-focused innovations.

    Leicester and Leicestershire High Priority Opportunity is providing innovative solutions at all stages of patient recovery. This Department of International Trade HPO aims to meet the growing national and international demand for pre-rehabilitation and rehabilitation solutions for real-world applications.
      Rehab and Trauma NRC  
  4. Health Data – A health data and AI powerhouse:

    Utilising the close relationship between our academic/clinical excellence and the region’s ethnically diverse population, we deliver the unparalleled opportunity to reduce development time and trial costs to innovate faster. This is demonstrated through our hosted infrastructure including: the UK’s only Centre for Patient Reported Outcomes, two Alan Turing Institute sites, four NHS England Global Digital Exemplars, one of the world’s largest Arm-based supercomputer deployments, the UK’s largest IBM Power9 AI cluster, the Midlands Health Data Research UK Substantive Sites3 Digital Innovation Hubs and some of the UK’s foremost diagnostic and experimental medicine capabilities (e.g. the UK’s largest NHS genetics service and Genomic Medicine Centre). All are supporting the largest cluster of digital start-ups outside of London.
  5. Clinical Trails – A proven track record of world-class delivery:

    The Midlands hosts significant and world-leading health research infrastructure in disease areas that are important for the nation’s health such as Respiratory, Cardiovascular, Gastrointestinal and Diabetes. The Midlands has outstanding clinical trials investigators and infrastructure that deliver a transformational approach. By combining rapid development and delivery with the ability to leverage expertise integrated within local infrastructure, the region hosts a world class clinical trials environment including: extensive NIHR infrastructure, the world’s largest precision medicine cancer CTU, the UK’s largest CTU, plus 2 Academic Health Science Networks and an Advanced Therapy Treatment Centre. This allows for the experienced delivery of adaptive trials at national and international scales.

MI Health, by drawing together this critical mass, can drive forward the country’s cutting edge health industry and power-up the NHS to deliver the country’s health needs.